BIVDA supports AMR Awareness Week
BIVDA has joined up with other healthcare organisations in support of Antimicrobial Awareness Week 2020. BIVDA CEO Doris-Ann Williams wrote a piece on the subject of AMR for The Guardian which launched on Tuesday 24th November inside a supplement dedicated to the campaign. The text explains the importance of diagnostic testing in the fight against antimicrobial resistance. AMR remains a global health disaster that is already killing 700,000 people a year. It is predicted to cause 10 million deaths each year by 2050 if the current situation is not improved.
The COVID-19 pandemic has highlighted the importance of diagnostics in our healthcare system and its ability to protect communities. 70% of patient information comes from diagnostic testing, a key element of healthcare which allows for correct treatment plans for patients to be identified. Testing can therefore help to diagnose patients more efficiently. For example, managing winter hospital admissions with influenza or pneumonia. Tests can distinguish between a bacterial or viral infection, allowing their symptoms to be treated most appropriately.
Inappropriate antibiotic prescriptions can be much reduced through the use of clinical diagnostic testing. After a treatment pathway is designated for a patient, testing then helps with monitoring its efficacy as long as the patient is ill. It is now essential to maximise our use of diagnostics in the most efficient way to fight AMR before it is out of our control.